Search

    BeiGene, Ltd.

    BGNE US07725L1026

    Cayman Islands KY1-1108
    Camana Bay C/O Mourant Ozannes Corporate Services (Cayman) Limited
    94 Solaris Avenue

    Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeiGene runs global clinical trials with its own team. As of 2023, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 50% of BeiGene's revenue.

    https://www.beigene.com

    Annual Performance 1
    2021 2022 2023 2024 2025
    4% -18% -20% 4% 0%
    Annual Insiders Turnover, USD 2

    1 annual and historical performance metrics are recalculated on a daily basis;
    2 represents the total value of insider transactions (both buying and selling);

    Insider Activity

    Transactions: 261 Insiders: 7

    Person Price Shares Total Published Completed
    OYLER JOHN
    		 252.23
    USD     		6,703
    Sold     		1,690,682
    USD     		09/07/2025 09/07/2025
    OYLER JOHN
    		 254.10
    USD     		10,254
    Sold     		2,605,577
    USD     		09/07/2025 09/07/2025
    OYLER JOHN
    		 254.83
    USD     		1,553
    Sold     		395,757
    USD     		09/07/2025 09/07/2025
    OYLER JOHN
    		 253.18
    USD     		9,292
    Sold     		2,352,575
    USD     		09/07/2025 09/07/2025
    Wang Xiaodong
    		 266.57
    USD     		507
    Sold     		135,149
    USD     		24/06/2025 24/06/2025
    Wang Xiaodong
    		 267.81
    USD     		100
    Sold     		26,781
    USD     		24/06/2025 24/06/2025
    Wang Xiaodong
    		 265.35
    USD     		1,100
    Sold     		291,888
    USD     		24/06/2025 24/06/2025
    Wang Xiaodong
    		 263.50
    USD     		300
    Sold     		79,050
    USD     		24/06/2025 24/06/2025
    OYLER JOHN
    		 261.57
    USD     		3,074
    Sold     		804,070
    USD     		23/06/2025 23/06/2025
    OYLER JOHN
    		 261.57
    USD     		3,074
    Sold     		804,070
    USD     		23/06/2025 23/06/2025

    Integrated EOD Stock Data and Insider Transactions Chart

    Sign in or subscribe to include BeiGene, Ltd. to your watchlist and receive automatic alerts for upcoming transactions.

    The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

     

    Historical Performance
    1M 3M 6M 1Y 3Y 5Y All Time
    -19% 19% 12% -11% -26% 164% 552%
    Last 52W Low 52W High All-Time Low All-Time High β
    184.71 174.72 215.00 23.98 403.14
    Company Insiders
    Person / Entity Transactions Turnover, USD Average, USD First Last
    OYLER JOHN 100 91,276,320.06 912,763.20 12/03/2024 09/07/2025
    Wang Xiaodong 80 81,400,007.68 1,017,500.10 26/11/2024 24/06/2025
    Wu Xiaobin 36 44,881,664.56 1,246,712.90 17/06/2024 23/06/2025
    Wang Lai 21 3,978,971.85 189,474.85 17/06/2024 23/06/2025
    Lee Chan Henry 15 1,713,895.07 114,259.67 17/06/2024 16/06/2025
    Wang Julia Aijun 7 419,865.32 59,980.76 29/02/2024 01/07/2024
    Ball Titus B. 2 60,642.01 30,321.01 03/09/2024 11/06/2025

    Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

    Connected Companies 3
    Name LEI ISIN Ticker
    C-Rad AB 549300SPXLHF15W2CU25 SE0002016352 CRADB

    3 the firms where the current insiders have executed transactions.

    Stock Advanced Metrics
    Delta Correlation subscribe 🔒
    Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

    4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

    5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.